TNSN99152A1 - ANTIOXIDANT AND ANTIPROLIFERATIVE COMPOSITION COMPRISING A CARNITINE AND A CAROTENOID - Google Patents

ANTIOXIDANT AND ANTIPROLIFERATIVE COMPOSITION COMPRISING A CARNITINE AND A CAROTENOID

Info

Publication number
TNSN99152A1
TNSN99152A1 TNTNSN99152A TNSN99152A TNSN99152A1 TN SN99152 A1 TNSN99152 A1 TN SN99152A1 TN TNSN99152 A TNTNSN99152 A TN TNSN99152A TN SN99152 A TNSN99152 A TN SN99152A TN SN99152 A1 TNSN99152 A1 TN SN99152A1
Authority
TN
Tunisia
Prior art keywords
carotenoid
carnitine
composition
antioxidant
dietetic
Prior art date
Application number
TNTNSN99152A
Other languages
French (fr)
Inventor
Cavazza Claudio
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of TNSN99152A1 publication Critical patent/TNSN99152A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

UNE COMPOSITION COMPRENANT COMME INGREDIENTS ACTIFS CARACTERISTIQUES LE PROPIONYL L-CARNITINE ET AU MOINS UN CAROTENOIDE SPECIFIQUEMENT LE LYCOPENE EXTRAIT A PARTIR DE TOMATES ET QUI EST DESTINES A LA PREVENTION ET/OU AU TRAITEMENT THERAPEUTIQUE DES DIFFERENTES ALTERATIONS ET ETATS PATHOLOGIQUES INDUITS PAR LA PRESENCE DE RADICAUX A L'ETAT LIBRE, ET PAR LE PHENOMENE DE LIPOPEROXYDATION. CETTE COMPOSITION PEUT AVOIR LA FORME D'UN SUPPLEMENT DIETETIQUE, D'UN SUPPORT DIETETIQUE OU D'UN MEDICAMENT EFFECTIFA COMPOSITION COMPRISING AS CHARACTERISTIC ACTIVE INGREDIENTS PROPIONYL L-CARNITINE AND AT LEAST ONE CAROTENOID SPECIFICALLY LYCOPENE EXTRACTED FROM TOMATOES AND WHICH ARE INTENDED FOR THE PREVENTION AND / OR THERAPEUTIC TREATMENT OF DIFFERENT DISEASES AND DISEASES IN THE FREE STATE, AND BY THE LIPOPEROXIDATION PHENOMENON. THIS COMPOSITION MAY HAVE THE FORM OF A DIETETIC SUPPLEMENT, A DIETETIC SUPPORT OR AN EFFECTIVE MEDICINAL PRODUCT

TNTNSN99152A 1998-08-03 1999-07-30 ANTIOXIDANT AND ANTIPROLIFERATIVE COMPOSITION COMPRISING A CARNITINE AND A CAROTENOID TNSN99152A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000516A IT1302125B1 (en) 1998-08-03 1998-08-03 COMPOSITION WITH ANTIOXIDANT AND ANTIPROLIFERATIVE ACTIVITY INCLUDING A CARNITINE AND A CAROTENOID

Publications (1)

Publication Number Publication Date
TNSN99152A1 true TNSN99152A1 (en) 2005-11-10

Family

ID=11406082

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN99152A TNSN99152A1 (en) 1998-08-03 1999-07-30 ANTIOXIDANT AND ANTIPROLIFERATIVE COMPOSITION COMPRISING A CARNITINE AND A CAROTENOID

Country Status (21)

Country Link
EP (1) EP1102584A2 (en)
JP (1) JP2002522382A (en)
KR (1) KR20010072146A (en)
CN (1) CN1311674A (en)
AR (1) AR021172A1 (en)
AU (1) AU5064199A (en)
BR (1) BR9912703A (en)
CA (1) CA2338035A1 (en)
EE (1) EE200100052A (en)
HK (1) HK1039062A1 (en)
HU (1) HUP0102807A2 (en)
IL (1) IL140797A0 (en)
IS (1) IS5816A (en)
IT (1) IT1302125B1 (en)
MA (1) MA26666A1 (en)
NO (1) NO20010532L (en)
PL (1) PL346161A1 (en)
SK (1) SK1252001A3 (en)
TN (1) TNSN99152A1 (en)
TR (1) TR200100333T2 (en)
WO (1) WO2000007581A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1286704T3 (en) 2000-06-02 2014-09-22 Univ Texas Ethylenedicine (EC) -glucose analog conjugates
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
KR100523562B1 (en) 2001-10-29 2005-10-25 한국과학기술연구원 Neuroprotective composition comprising an extract from opuntia ficus-indica and compounds isolated therefrom
JP4527938B2 (en) * 2002-07-23 2010-08-18 オルビス株式会社 Orally administered composition for antioxidant
JP4334189B2 (en) * 2002-07-30 2009-09-30 カゴメ株式会社 AGE production inhibitor
ITRM20020620A1 (en) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti USE OF CARNITINE FOR THE PREVENTION AND / OR TREATMENT OF DISORDERS CAUSED BY ANDROPAUSE.
WO2004092153A1 (en) 2003-04-14 2004-10-28 Nippon Soda Co. Ltd. Diamine derivative, production process, and antioxidizing drug
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
BRPI0507253A (en) * 2004-01-28 2007-06-26 Nestec Sa nutritional composition to improve skin conditions and prevent skin diseases
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
RU2619342C1 (en) * 2016-02-24 2017-05-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Medication for prevention and treatment of free radical pathology in animals
CN113491687A (en) * 2020-04-02 2021-10-12 常州高新技术产业开发区三维工业技术研究所有限公司 Detoxifying medicine composition and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
IT1276225B1 (en) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ALKANOYL L-CARNITINE IN ASSOCIATION WITH RESVERATROL OR ITS DERIVATIVES USEFUL FOR
IT1277953B1 (en) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR AN ALCANOYL L-CARNITINE AND A 3-OMEGA SERIES POLYUNSATURED ACID USEFUL
IT1283967B1 (en) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti USE OF L-CARNITINE OR L-CARNITINE DERIVATIVES AND ANTIOXIDANTS IN THE PREVENTION AND TREATMENT OF PATHOLOGIES ARISING FROM OXIDATIVE DAMAGES
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
EP1021177A4 (en) * 1997-02-04 2002-05-15 John V Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (en) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS

Also Published As

Publication number Publication date
WO2000007581A2 (en) 2000-02-17
MA26666A1 (en) 2004-12-20
TR200100333T2 (en) 2001-07-23
NO20010532L (en) 2001-03-20
ITRM980516A0 (en) 1998-08-03
JP2002522382A (en) 2002-07-23
CA2338035A1 (en) 2000-02-17
SK1252001A3 (en) 2001-08-06
HUP0102807A2 (en) 2002-03-28
IT1302125B1 (en) 2000-07-31
IS5816A (en) 2001-01-16
KR20010072146A (en) 2001-07-31
AU5064199A (en) 2000-02-28
WO2000007581A3 (en) 2000-05-11
BR9912703A (en) 2001-05-02
PL346161A1 (en) 2002-01-28
ITRM980516A1 (en) 2000-02-03
EP1102584A2 (en) 2001-05-30
HK1039062A1 (en) 2002-04-12
IL140797A0 (en) 2002-02-10
NO20010532D0 (en) 2001-01-31
CN1311674A (en) 2001-09-05
AR021172A1 (en) 2002-07-03
EE200100052A (en) 2002-06-17

Similar Documents

Publication Publication Date Title
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
TNSN99152A1 (en) ANTIOXIDANT AND ANTIPROLIFERATIVE COMPOSITION COMPRISING A CARNITINE AND A CAROTENOID
NO20012954L (en) Oil-in-water emulsion comprising a micronized biologically active agent and a suitable emulsifier system
FR2715582B1 (en) Microcapsules with crosslinked flavonoid walls and compositions containing them.
DE69815323D1 (en) THERAPEUTIC FOOD FOR DIABETICS
CA2229624A1 (en) Method of reducing bodyweight and treating obesity
TNSN99132A1 (en) A COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF OSTEOPOROSIS OR ALTERATIONS DUE TO MENOPAUSE SYNDROME
EP1163905A4 (en) Skin preparations for external use
WO1999066914A3 (en) Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin
CA2334919A1 (en) Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
CO5221082A1 (en) FILLERS CONTAINING MOISTURE NOT BASED ON EMULSION, FOR MASS PRODUCTS
ATE271392T1 (en) LIPOPROTEIN COMPLEXES AND COMPOSITIONS CONTAINING SAME
CA2253130A1 (en) A medicament for treating obesity and improving lipid metabolism
CA2258503A1 (en) Lectin compositions and uses thereof
BR0011447A (en) Composition comprising alkaline sphingomyelinase for application as a dietary preparation, food supplement or pharmaceutical product
CA2124605A1 (en) Prevention and improvement of medical symptoms caused by leucotriene b4
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
TNSN99138A1 (en) AN ANTIOXIDANT, CYTOSTATIC AND ENERGY SUPPORTED COMPOSITION THAT IMPROVES THE METABOLIC USE OF GLUCOSE
TNSN99212A1 (en) ANTIOXIDANT AND PREVENTIVE COMPOSITION AGAINST THROMBOTIC AND ATHEROSCLEROTIC ANOMALIES, COMPRISING A CARNITINE AND A FLAVONOID
TNSN96016A1 (en) USE OF PHENYLCYCLOHEXYLCARBOXAMIDES
CA2291811A1 (en) Zinc and linoleic acid containing food
DE3750426D1 (en) Means to improve specific properties of the blood.
NO20022288L (en) Composition for the prevention and / or treatment of disorders caused by abnormal lipid metabolism, including propionyl L-carnitine and chitosan
ATE214935T1 (en) ROBINIA PSEUDOACACIA LECTIN AND ITS USES
NO955347L (en) Hormonal agent for the therapy of acne and its use